Global Autologous Cell Therapy Market Size Study, by Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), by Source (Bone Marrow, Peripheral Blood, Adipose Tissue, Others),

Global Autologous Cell Therapy Market Size Study, by Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), by Source (Bone Marrow, Peripheral Blood, Adipose Tissue, Others), by End-Use (Hospitals, Academics & Research, Others), and Regional Forecasts 2022-2032


The Global Autologous Cell Therapy Market is valued approximately at USD 4.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 22.20% over the forecast period 2024-2030. Autologous cell therapy involves using a patient's cells, typically derived from tissues like bone marrow or blood, to treat various medical conditions. These cells are harvested from the patient, processed to isolate specific types of cells (such as stem cells or immune cells), and then reintroduced into the patient's body. Autologous cell therapy is used in treatments for conditions such as cancer, autoimmune diseases, and certain genetic disorders, aiming to harness the body's own regenerative or immune capabilities for therapeutic benefit. The Global Autologous Cell Therapy Market is experiencing robust growth driven by several key factors. The rise in the geriatric population and the increasing prevalence of chronic diseases such as cancer and neurodegenerative disorders are significantly driving the market growth.

The rise in the geriatric population and the increasing prevalence of chronic diseases such as cancer and neurodegenerative disorders are significant contributors. The aging population leads to a higher incidence of age-related ailments, necessitating advanced treatment options. Simultaneously, the growing number of patients diagnosed with chronic conditions highlights the urgent need for innovative therapies, making autologous cell therapy a critical area of development and investment in the healthcare sector. Moreover, the market is witnessing technological advancements in cell isolation and expansion, making these therapies more accessible and cost-effective. For instance, in March 2024, the FDA approved Breyanzi by Bristol Myers Squibb for adults with CLL or SLL that is relapsed or refractory. This CAR-T cell therapy is given as a one-time infusion. The clinical trials and market expansions of key players are enhancing the market dynamics. Moreover, increasing investment and research in autologous cell therapies and adoption of personalized medicine are creating new opportunities to the market growth. However, the high cost of autologous cell therapy, Stringent Regulatory Requirements are hindering the market growth during the projected period 2024-2032.

Key regions considered for the global Autologous Cell Therapy market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market, driven by the presence of major market players and advanced healthcare infrastructure. The U.S. held the largest share in the North American region and is expected to grow rapidly over the forecast period due to FDA approvals and increasing investments. Europe also shows significant potential, with supportive regulatory environments and substantial funding for research. The Asia-Pacific region is anticipated to witness the fastest growth due to the rising burden of diseases and strong research activities in autologous cell therapies.

Major market players included in this report are:

BrainStorm Cell Therapeutics

Holostem Terapie Avanzate S.R.L

Pharmicell Co. Inc

Opexa Therapeutics

Caladrius Biosciences Inc

U.S. Stem Cell Inc

Lonza Group AG

Bristol Myers Squibb

Novartis AG

The detailed segments and sub-segment of the market are explained below:

By Application:

Cancer

Neurodegenerative Disorders

Cardiovascular Disorders

Autoimmune Disorders

Orthopedics

Wound Healing

Others

By Source:

Bone Marrow

Peripheral Blood

Adipose Tissue

Others

By End-Use:

Hospitals

Academics & Research

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Global Autologous Cell Therapy Market Executive Summary
1.1. Global Autologous Cell Therapy Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Application
1.3.2. By Source
1.3.3. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Autologous Cell Therapy Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Autologous Cell Therapy Market Dynamics
3.1. Market Drivers
3.1.2. Rising Geriatric Population
3.1.3 Prevalence of Chronic Diseases
3.1.3. Technological Advancements and Innovation in Cell Therapies
3.2. Market Challenges
3.2.1. High Costs and Complex Manufacturing Processes
3.2.2. Stringent Regulatory Requirements
3.3. Market Opportunities
3.3.2. Increasing Investment and Research in Autologous Cell Therapies
3.3.3. Adoption of Personalized Medicine
Chapter 4. Global Autologous Cell Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Autologous Cell Therapy Market Size & Forecasts by Application 2022-2032
5.1. Segment Dashboard
5.2. Global Autologous Cell Therapy Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Cancer
5.2.2. Neurodegenerative Disorders
5.2.3. Cardiovascular Disorders
5.2.4. Autoimmune Disorders
5.2.5. Orthopedics
5.2.6. Wound Healing
5.2.7. Others
Chapter 6. Global Autologous Cell Therapy Market Size & Forecasts by Source 2022-2032
6.1. Segment Dashboard
6.2. Global Autologous Cell Therapy Market: Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Bone Marrow
6.2.2. Peripheral Blood
6.2.3. Adipose Tissue
6.2.4. Others
Chapter 7. Global Autologous Cell Therapy Market Size & Forecasts by End-Use 2022-2032
7.1. Segment Dashboard
7.2. Global Autologous Cell Therapy Market: End-Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Academics & Research
7.2.3. Others
Chapter 8. Global Autologous Cell Therapy Market Size & Forecasts by Region 2022-2032
8.1. North America Autologous Cell Therapy Market
8.1.1. U.S. Autologous Cell Therapy Market
8.1.1.1. Application breakdown size & forecasts, 2022-2032
8.1.1.2. Source breakdown size & forecasts, 2022-2032
8.1.1.3. End-Use breakdown size & forecasts, 2022-2032
8.1.2. Canada Autologous Cell Therapy Market
8.1.2.1. Application breakdown size & forecasts, 2022-2032
8.1.2.2. Source breakdown size & forecasts, 2022-2032
8.1.2.3. End-Use breakdown size & forecasts, 2022-2032
8.2. Europe Autologous Cell Therapy Market
8.2.1. UK Autologous Cell Therapy Market
8.2.1.1. Application breakdown size & forecasts, 2022-2032
8.2.1.2. Source breakdown size & forecasts, 2022-2032
8.2.1.3. End-Use breakdown size & forecasts, 2022-2032
8.2.2. Germany Autologous Cell Therapy Market
8.2.2.1. Application breakdown size & forecasts, 2022-2032
8.2.2.2. Source breakdown size & forecasts, 2022-2032
8.2.2.3. End-Use breakdown size & forecasts, 2022-2032
8.2.3. France Autologous Cell Therapy Market
8.2.3.1. Application breakdown size & forecasts, 2022-2032
8.2.3.2. Source breakdown size & forecasts, 2022-2032
8.2.3.3. End-Use breakdown size & forecasts, 2022-2032
8.2.4. Spain Autologous Cell Therapy Market
8.2.4.1. Application breakdown size & forecasts, 2022-2032
8.2.4.2. Source breakdown size & forecasts, 2022-2032
8.2.4.3. End-Use breakdown size & forecasts, 2022-2032
8.2.5. Italy Autologous Cell Therapy Market
8.2.5.1. Application breakdown size & forecasts, 2022-2032
8.2.5.2. Source breakdown size & forecasts, 2022-2032
8.2.5.3. End-Use breakdown size & forecasts, 2022-2032
8.2.6. Rest of Europe Autologous Cell Therapy Market
8.2.6.1. Application breakdown size & forecasts, 2022-2032
8.2.6.2. Source breakdown size & forecasts, 2022-2032
8.2.6.3. End-Use breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Autologous Cell Therapy Market
8.3.1. China Autologous Cell Therapy Market
8.3.1.1. Application breakdown size & forecasts, 2022-2032
8.3.1.2. Source breakdown size & forecasts, 2022-2032
8.3.1.3. End-Use breakdown size & forecasts, 2022-2032
8.3.2. India Autologous Cell Therapy Market
8.3.2.1. Application breakdown size & forecasts, 2022-2032
8.3.2.2. Source breakdown size & forecasts, 2022-2032
8.3.2.3. End-Use breakdown size & forecasts, 2022-2032
8.3.3. Japan Autologous Cell Therapy Market
8.3.3.1. Application breakdown size & forecasts, 2022-2032
8.3.3.2. Source breakdown size & forecasts, 2022-2032
8.3.3.3. End-Use breakdown size & forecasts, 2022-2032
8.3.4. Australia Autologous Cell Therapy Market
8.3.4.1. Application breakdown size & forecasts, 2022-2032
8.3.4.2. Source breakdown size & forecasts, 2022-2032
8.3.4.3. End-Use breakdown size & forecasts, 2022-2032
8.3.5. South Korea Autologous Cell Therapy Market
8.3.5.1. Application breakdown size & forecasts, 2022-2032
8.3.5.2. Source breakdown size & forecasts, 2022-2032
8.3.5.3. End-Use breakdown size & forecasts, 2022-2032
8.3.6. Rest of Asia Pacific Autologous Cell Therapy Market
8.3.6.1. Application breakdown size & forecasts, 2022-2032
8.3.6.2. Source breakdown size & forecasts, 2022-2032
8.3.6.3. End-Use breakdown size & forecasts, 2022-2032
8.4. Latin America Autologous Cell Therapy Market
8.4.1. Brazil Autologous Cell Therapy Market
8.4.1.1. Application breakdown size & forecasts, 2022-2032
8.4.1.2. Source breakdown size & forecasts, 2022-2032
8.4.1.3. End-Use breakdown size & forecasts, 2022-2032
8.4.2. Mexico Autologous Cell Therapy Market
8.4.2.1. Application breakdown size & forecasts, 2022-2032
8.4.2.2. Source breakdown size & forecasts, 2022-2032
8.4.2.3. End-Use breakdown size & forecasts, 2022-2032
8.4.3. Rest of Latin America Autologous Cell Therapy Market
8.4.3.1. Application breakdown size & forecasts, 2022-2032
8.4.3.2. Source breakdown size & forecasts, 2022-2032
8.4.3.3. End-Use breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Autologous Cell Therapy Market
8.5.1. Saudi Arabia Autologous Cell Therapy Market
8.5.1.1. Application breakdown size & forecasts, 2022-2032
8.5.1.2. Source breakdown size & forecasts, 2022-2032
8.5.1.3. End-Use breakdown size & forecasts, 2022-2032
8.5.2. South Africa Autologous Cell Therapy Market
8.5.2.1. Application breakdown size & forecasts, 2022-2032
8.5.2.2. Source breakdown size & forecasts, 2022-2032
8.5.2.3. End-Use breakdown size & forecasts, 2022-2032
8.5.3. Rest of Middle East & Africa Autologous Cell Therapy Market
8.5.3.1. Application breakdown size & forecasts, 2022-2032
8.5.3.2. Source breakdown size & forecasts, 2022-2032
8.5.3.3. End-Use breakdown size & forecasts, 2022-2032
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1Company 1
9.1.2 Company 2
9.1.3 Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. BrainStorm Cell Therapeutics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Holostem Terapie Avanzate S.R.L
9.3.3. Pharmicell Co. Inc
9.3.4. Opexa Therapeutics
9.3.5. Caladrius Biosciences Inc
9.3.6. U.S. Stem Cell Inc
9.3.7. Lonza
9.3.8. Bristol Myers Squibb
9.3.9. Novartis
9.3.10. Autolus Therapeutics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Autologous Cell Therapy market, report scope
TABLE 2. Global Autologous Cell Therapy market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Autologous Cell Therapy market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 4. Global Autologous Cell Therapy market estimates & forecasts by Source 2022-2032 (USD Billion)
TABLE 5. Global Autologous Cell Therapy market estimates & forecasts by End-Use 2022-2032 (USD Billion)
TABLE 6. Global Autologous Cell Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Autologous Cell Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Autologous Cell Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Autologous Cell Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Autologous Cell Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Autologous Cell Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Autologous Cell Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Autologous Cell Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Autologous Cell Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Autologous Cell Therapy market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Autologous Cell Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Autologous Cell Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Autologous Cell Therapy market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Autologous Cell Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Autologous Cell Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Autologous Cell Therapy market, research methodology
FIGURE 2. Global Autologous Cell Therapy market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Autologous Cell Therapy market, key trends 2023
FIGURE 5. Global Autologous Cell Therapy market, growth prospects 2022-2032
FIGURE 6. Global Autologous Cell Therapy market, porters 5 force model
FIGURE 7. Global Autologous Cell Therapy market, PESTEL analysis
FIGURE 8. Global Autologous Cell Therapy market, value chain analysis
FIGURE 9. Global Autologous Cell Therapy market by segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Autologous Cell Therapy market by segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Autologous Cell Therapy market by segment, 2022 & 2032 (USD Billion)
FIGURE 12. Global Autologous Cell Therapy market by segment, 2022 & 2032 (USD Billion)
FIGURE 13. Global Autologous Cell Therapy market by segment, 2022 & 2032 (USD Billion)
FIGURE 14. Global Autologous Cell Therapy market, regional snapshot 2022 & 2032
FIGURE 15. North America Autologous Cell Therapy market 2022 & 2032 (USD Billion)
FIGURE 16. Europe Autologous Cell Therapy market 2022 & 2032 (USD Billion)
FIGURE 17. Asia Pacific Autologous Cell Therapy market 2022 & 2032 (USD Billion)
FIGURE 18. Latin America Autologous Cell Therapy market 2022 & 2032 (USD Billion)
FIGURE 19. Middle East & Africa Autologous Cell Therapy market 2022 & 2032 (USD Billion)
FIGURE 20. Global Autologous Cell Therapy market, company market share analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings